{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:42:28Z","timestamp":1775706148465,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"vor","delay-in-days":343,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ajpath.2013.10.008","type":"journal-article","created":{"date-parts":[[2014,1,6]],"date-time":"2014-01-06T00:45:16Z","timestamp":1388969116000},"page":"369-375","source":"Crossref","is-referenced-by-count":51,"title":["A Novel Vascular Homing Peptide Strategy to Selectively Enhance Pulmonary Drug Efficacy in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"184","author":[{"given":"Michie","family":"Toba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah","family":"Alzoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kealan","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Urakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tero A.H.","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkki","family":"Ruoslahti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan F.","family":"McMurtry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.10.008_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpath.2013.10.008_bib2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.10.008_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.RES.0000111804.34509.94","article-title":"Long-term treatment with a rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats","volume":"94","author":"Abe","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.10.008_bib4","doi-asserted-by":"crossref","first-page":"L665","DOI":"10.1152\/ajplung.00050.2003","article-title":"Rho\/rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats","volume":"287","author":"Nagaoka","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.RES.0000261658.12024.18","article-title":"Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats","volume":"100","author":"Oka","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.10.008_bib6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCULATIONAHA.111.060269","article-title":"Microrna-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach","volume":"125","author":"Parikh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.10.008_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1165\/rcmb.2010-0371OC","article-title":"Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats","volume":"45","author":"Abe","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib8","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.10.008_bib9","doi-asserted-by":"crossref","first-page":"H541","DOI":"10.1152\/ajpheart.00770.2006","article-title":"Rho kinase contributes to basal vascular tone in humans: role of endothelium-derived nitric oxide","volume":"293","author":"Bussemaker","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib10","doi-asserted-by":"crossref","first-page":"H184","DOI":"10.1152\/ajpheart.00181.2009","article-title":"Analysis of responses to the rho-kinase inhibitory-27632 in the pulmonary and systemic vascular bed of the rat","volume":"299","author":"Casey","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkela","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2013.10.008_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CRD.0b013e3181cbcbf3","article-title":"New approaches to the treatment of pulmonary hypertension: from bench to bedside","volume":"18","author":"Murthy","year":"2010","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.ajpath.2013.10.008_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/rccm.200405-637OC","article-title":"Inhaled rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension","volume":"171","author":"Nagaoka","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2013.10.008_bib14","first-page":"233","article-title":"Inhalatory therapy training: a priority challenge for the physician","volume":"78","author":"Melani","year":"2007","journal-title":"Acta Biomed"},{"key":"10.1016\/j.ajpath.2013.10.008_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00380-009-1176-8","article-title":"Acute vasodilator effects of inhaled fasudil, a specific rho-kinase inhibitor, in patients with pulmonary arterial hypertension","volume":"25","author":"Fujita","year":"2010","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ajpath.2013.10.008_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/bst0320397","article-title":"Vascular zip codes in angiogenesis and metastasis","volume":"32","author":"Ruoslahti","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ajpath.2013.10.008_bib17","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1002\/adma.201200454","article-title":"Peptides as targeting elements and tissue penetration devices for nanoparticles","volume":"24","author":"Ruoslahti","year":"2012","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajpath.2013.10.008_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2013.10.008_bib19","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","author":"Teesalu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.10.008_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.10.008_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2353\/ajpath.2007.061251","article-title":"Molecular changes in the vasculature of injured tissues","volume":"171","author":"J\u00e4rvinen","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib22","doi-asserted-by":"crossref","first-page":"21671","DOI":"10.1073\/pnas.1016233107","article-title":"Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice","volume":"107","author":"J\u00e4rvinen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2013.10.008_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/wound.2011.0299","article-title":"Targeted antiscarring therapy for tissue injuries","volume":"2","author":"J\u00e4rvinen","year":"2013","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.ajpath.2013.10.008_bib24","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.ajpath.2011.02.032","article-title":"Peptide-directed highly selective targeting of pulmonary arterial hypertension","volume":"178","author":"Urakami","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib25","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ajpath.2013.10.008_bib26","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000247065.11756.19","article-title":"Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury","volume":"99","author":"Alvarez","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.10.008_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Taraseviciene-Stewart","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2013.10.008_bib28","doi-asserted-by":"crossref","first-page":"H1288","DOI":"10.1152\/ajpheart.00329.2013","article-title":"Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in the pulmonary and systemic vascular beds in the rat","volume":"305","author":"Pankey","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2013.10.008_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1399-3011.1999.00052.x","article-title":"Solution stability of linear vs. cyclic RGD peptides","volume":"53","author":"Bogdanowich-Knipp","year":"1999","journal-title":"J Pept Res"},{"key":"10.1016\/j.ajpath.2013.10.008_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J Control Release"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013007207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013007207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T16:51:18Z","timestamp":1538931078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013007207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0002944013007207"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.10.008","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}